Annual Revenue
$2.58B$16.70M+0.65%
Summary
- Current Value
- As of today, BIO annual revenue is $2.58B, up +0.65% on
- Historical Performance
- BIO annual revenue is down -7.82% over the past 3 years, up +1.48% over the past 5 years
- All-Time High Comparison
- BIO annual revenue is currently -11.61% below its historical high of $2.92B set on
- 3-Year Low Comparison
- BIO annual revenue is +0.65% above its 3-year low of $2.57B reached on
- Sector Comparison
- BIO annual revenue is higher than 89.60% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO annual revenue at $2.57B, -0.38% lower than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for BIO has not been scheduled
Revenue Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $2.58B | +0.7% | -7.8% | +1.5% | +34.0% | |
| Quarterly Revenue | $651.00M | -0.1% | -4.4% | -9.1% | +24.8% | |
| TTM Revenue | $2.59B | +1.4% | -6.5% | -10.1% | +28.7% | |
| Price | $386.11 | +33.4% | -2.1% | -52.9% | +296.7% | |
| Annual EPS | $27.85 | +142.6% | +122.9% | -77.9% | +322.7% | |
| PE Ratio | 46.78 | +89.6% | – | +665.6% | +215.7% | |
| Annual Gross Profit | $1.34B | -2.6% | -14.3% | -6.4% | +23.1% | |
| Annual Net Income | $759.90M | +141.2% | +121.0% | -80.0% | +306.5% | |
| Annual EBITDA | $475.90M | -5.5% | -27.5% | -18.0% | +21.1% | |
| $270.50M | -13.0% | -43.6% | -33.2% | -4.8% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.80B | N/A | -7.8% |
| 5Y | $2.92B | -11.6% | |
| All | $2.92B | -11.6% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.57B | +0.7% | |
| 5Y | $2.55B | N/A | +1.5% |
| All | $46.09M | +5505.3% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.58B | $2.57B | -0.56% | |
| $2.58B | $2.58B | +0.17% | |
| $2.57B | N/A | -0.38% | |
| $2.63B | N/A | +1.95% |
🔒 Log In To Unlock Full Data
Revenue History
FAQ
- What is the current annual revenue of BIO?
- As of today, BIO annual revenue is $2.58B
- What is 1-year change in BIO annual revenue?
- BIO annual revenue is up +0.65% year-over-year
- What is 3-year change in BIO annual revenue?
- BIO annual revenue is down -7.82% over the past 3 years
- How far is BIO annual revenue from its all-time high?
- BIO annual revenue is currently -11.61% below its historical high of $2.92B set on December 31, 2021
- How does BIO annual revenue rank versus sector peers?
- BIO annual revenue is higher than 89.60% of companies in Healthcare sector
- How does the analyst estimate for BIO annual revenue compare to its current value?
- Analysts estimate BIO annual revenue at $2.57B, -0.38% lower than the current value
- When is BIO next annual earnings release?
- As of today, the next annual earnings release for BIO has not been scheduled
Quarterly Revenue
$651.00M$58.90M+9.95%
Summary
- Current Value
- As of today, BIO quarterly revenue is $651.00M, up +9.95% on
- Historical Performance
- BIO quarterly revenue is down -0.09% year-over-year, down -4.42% over the past 3 years
- All-Time High Comparison
- BIO quarterly revenue is currently -17.58% below its historical high of $789.84M set on
- 3-Year Low Comparison
- BIO quarterly revenue is +11.21% above its 3-year low of $585.40M reached on
- Sector Comparison
- BIO quarterly revenue is higher than 88.71% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO quarterly revenue at $650.65M, -0.05% lower than the current value
- Upcoming Earnings
- The next earnings release for BIO is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $651.00M | +9.9% | -0.1% | -4.4% | -9.1% | |
| Annual Revenue | $2.58B | – | +0.7% | -7.8% | +1.5% | |
| TTM Revenue | $2.59B | -0.0% | +1.4% | -6.5% | -10.1% | |
| Price | $386.11 | +25.6% | +33.4% | -2.1% | -52.9% | |
| Quarterly EPS | $13.85 | +170.8% | +18.7% | +135.0% | -54.3% | |
| PE Ratio | 46.78 | -7.6% | +89.6% | – | +665.6% | |
| Quarterly Gross Profit | $345.80M | +11.8% | +0.1% | -5.5% | -14.1% | |
| Quarterly Net Income | $371.40M | +170.5% | +16.9% | +132.0% | -59.4% | |
| $72.60M | +112.9% | -8.7% | -27.6% | -38.0% | ||
| Quarterly EBITDA | $123.20M | +45.5% | -5.3% | -22.0% | -23.3% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $693.20M | -6.1% | |
| 3Y | $693.20M | -6.1% | |
| 5Y | $747.05M | -12.9% | |
| All | $789.84M | -17.6% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $592.10M | +9.9% | |
| 3Y | $585.40M | +11.2% | |
| 5Y | $585.40M | +11.2% | |
| All | $20.10M | +3138.8% |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $588.86M | $592.10M | +0.55% | |
| $623.99M | $651.00M | +4.33% | |
| $650.65M | N/A | -0.05% | |
| $689.90M | N/A | +5.98% |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
- What is the current quarterly revenue of BIO?
- As of today, BIO quarterly revenue is $651.00M
- What is BIO quarterly revenue most recent change?
- BIO quarterly revenue was up +9.95% on June 30, 2026
- What is 1-year change in BIO quarterly revenue?
- BIO quarterly revenue is down -0.09% year-over-year
- How far is BIO quarterly revenue from its all-time high?
- BIO quarterly revenue is currently -17.58% below its historical high of $789.84M set on December 31, 2020
- How does BIO quarterly revenue rank versus sector peers?
- BIO quarterly revenue is higher than 88.71% of companies in Healthcare sector
- How does the analyst estimate for BIO quarterly revenue compare to its current value?
- Analysts estimate BIO quarterly revenue at $650.65M, -0.05% lower than the current value
- When is BIO next earnings release?
- The next earnings release for BIO is on
TTM Revenue
$2.59B$600.00K-0.02%
Summary
- Current Value
- As of today, BIO TTM revenue is $2.59B, down -0.02% on
- Historical Performance
- BIO TTM revenue is up +1.37% year-over-year, down -6.49% over the past 3 years
- All-Time High Comparison
- BIO TTM revenue is currently -13.10% below its historical high of $2.98B set on
- 3-Year Low Comparison
- BIO TTM revenue is +1.90% above its 3-year low of $2.54B reached on
- Sector Comparison
- BIO TTM revenue is higher than 88.81% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO TTM revenue at $2.59B, -0.09% lower than the current value
- Upcoming Earnings
- The next earnings release for BIO is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $2.59B | -0.0% | +1.4% | -6.5% | -10.1% | |
| Annual Revenue | $2.58B | – | +0.7% | -7.8% | +1.5% | |
| Quarterly Revenue | $651.00M | +9.9% | -0.1% | -4.4% | -9.1% | |
| Price | $386.11 | +25.6% | +33.4% | -2.1% | -52.9% | |
| TTM EPS | $8.25 | +35.9% | -29.7% | +155.2% | -93.8% | |
| PE Ratio | 46.78 | -7.6% | +89.6% | – | +665.6% | |
| TTM Gross Profit | $1.34B | +0.0% | -1.8% | -10.4% | -18.9% | |
| TTM Net Income | $222.40M | +31.8% | -30.3% | +151.9% | -94.5% | |
| TTM EBITDA | $442.80M | -1.5% | -13.6% | -23.5% | -40.6% | |
| $235.00M | -2.9% | -25.5% | -38.4% | -58.8% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.59B | -0.0% | |
| 3Y | $2.77B | N/A | -6.5% |
| 5Y | $2.98B | -13.1% | |
| All | $2.98B | -13.1% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.55B | N/A | +1.4% |
| 3Y | $2.54B | +1.9% | |
| 5Y | $2.54B | +1.9% | |
| All | $20.50M | >+9999.0% |
TTM Revenue History
FAQ
- What is the current TTM revenue of BIO?
- As of today, BIO TTM revenue is $2.59B
- What is BIO TTM revenue most recent change?
- BIO TTM revenue was down -0.02% on June 30, 2026
- What is 1-year change in BIO TTM revenue?
- BIO TTM revenue is up +1.37% year-over-year
- How far is BIO TTM revenue from its all-time high?
- BIO TTM revenue is currently -13.10% below its historical high of $2.98B set on September 30, 2021
- How does BIO TTM revenue rank versus sector peers?
- BIO TTM revenue is higher than 88.81% of companies in Healthcare sector
- How does the analyst estimate for BIO TTM revenue compare to its current value?
- Analysts estimate BIO TTM revenue at $2.59B, -0.09% lower than the current value
- When is BIO next earnings release?
- The next earnings release for BIO is on
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220826000010/0000012208-26-000010-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio
